These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 25234288

  • 1. Comprehensive analysis of RET and ROS1 rearrangement in lung adenocarcinoma.
    Lee SE, Lee B, Hong M, Song JY, Jung K, Lira ME, Mao M, Han J, Kim J, Choi YL.
    Mod Pathol; 2015 Apr; 28(4):468-79. PubMed ID: 25234288
    [Abstract] [Full Text] [Related]

  • 2. ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: a comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features.
    Pan Y, Zhang Y, Li Y, Hu H, Wang L, Li H, Wang R, Ye T, Luo X, Zhang Y, Li B, Cai D, Shen L, Sun Y, Chen H.
    Lung Cancer; 2014 May; 84(2):121-6. PubMed ID: 24629636
    [Abstract] [Full Text] [Related]

  • 3. On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas.
    Mescam-Mancini L, Lantuéjoul S, Moro-Sibilot D, Rouquette I, Souquet PJ, Audigier-Valette C, Sabourin JC, Decroisette C, Sakhri L, Brambilla E, McLeer-Florin A.
    Lung Cancer; 2014 Feb; 83(2):168-73. PubMed ID: 24380695
    [Abstract] [Full Text] [Related]

  • 4. Decoding Tumor Phenotypes for ALK, ROS1, and RET Fusions in Lung Adenocarcinoma Using a Radiomics Approach.
    Yoon HJ, Sohn I, Cho JH, Lee HY, Kim JH, Choi YL, Kim H, Lee G, Lee KS, Kim J.
    Medicine (Baltimore); 2015 Oct; 94(41):e1753. PubMed ID: 26469915
    [Abstract] [Full Text] [Related]

  • 5. From genotype to phenotype: Are there imaging characteristics associated with lung adenocarcinomas harboring RET and ROS1 rearrangements?
    Plodkowski AJ, Drilon A, Halpenny DF, O'Driscoll D, Blair D, Litvak AM, Zheng J, Moskowitz CS, Ginsberg MS.
    Lung Cancer; 2015 Nov; 90(2):321-5. PubMed ID: 26424208
    [Abstract] [Full Text] [Related]

  • 6. Clinicopathological characteristics and survival of ALK, ROS1 and RET rearrangements in non-adenocarcinoma non-small cell lung cancer patients.
    Song Z, Yu X, Zhang Y.
    Cancer Biol Ther; 2017 Nov 02; 18(11):883-887. PubMed ID: 27635639
    [Abstract] [Full Text] [Related]

  • 7. [Detection of ALK, ROS1 and RET fusion genes in non-small cell lung cancer patients and its clinicopathologic correlation].
    Zhong S, Zhang H, Bai D, Gao D, Zheng J, Ding Y.
    Zhonghua Bing Li Xue Za Zhi; 2015 Sep 02; 44(9):639-43. PubMed ID: 26705279
    [Abstract] [Full Text] [Related]

  • 8. Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions.
    Suehara Y, Arcila M, Wang L, Hasanovic A, Ang D, Ito T, Kimura Y, Drilon A, Guha U, Rusch V, Kris MG, Zakowski MF, Rizvi N, Khanin R, Ladanyi M.
    Clin Cancer Res; 2012 Dec 15; 18(24):6599-608. PubMed ID: 23052255
    [Abstract] [Full Text] [Related]

  • 9. ALK, ROS1 and RET rearrangements in lung squamous cell carcinoma are very rare.
    Zhao W, Choi YL, Song JY, Zhu Y, Xu Q, Zhang F, Jiang L, Cheng J, Zheng G, Mao M.
    Lung Cancer; 2016 Apr 15; 94():22-7. PubMed ID: 26973202
    [Abstract] [Full Text] [Related]

  • 10. A single-tube multiplexed assay for detecting ALK, ROS1, and RET fusions in lung cancer.
    Lira ME, Choi YL, Lim SM, Deng S, Huang D, Ozeck M, Han J, Jeong JY, Shim HS, Cho BC, Kim J, Ahn MJ, Mao M.
    J Mol Diagn; 2014 Mar 15; 16(2):229-43. PubMed ID: 24418728
    [Abstract] [Full Text] [Related]

  • 11. Identification of ALK, ROS1, and RET Fusions by a Multiplexed mRNA-Based Assay in Formalin-Fixed, Paraffin-Embedded Samples from Advanced Non-Small-Cell Lung Cancer Patients.
    Reguart N, Teixidó C, Giménez-Capitán A, Paré L, Galván P, Viteri S, Rodríguez S, Peg V, Aldeguer E, Viñolas N, Remon J, Karachaliou N, Conde E, Lopez-Rios F, Nadal E, Merkelbach-Bruse S, Büttner R, Rosell R, Molina-Vila MA, Prat A.
    Clin Chem; 2017 Mar 15; 63(3):751-760. PubMed ID: 28073897
    [Abstract] [Full Text] [Related]

  • 12. Expression of C-terminal ALK, RET, or ROS1 in lung cancer cells with or without fusion.
    Furugaki K, Mochizuki M, Kohno M, Shu S, Harada N, Yoshimura Y.
    BMC Cancer; 2019 Apr 03; 19(1):301. PubMed ID: 30943926
    [Abstract] [Full Text] [Related]

  • 13. RET, ROS1 and ALK fusions in lung cancer.
    Takeuchi K, Soda M, Togashi Y, Suzuki R, Sakata S, Hatano S, Asaka R, Hamanaka W, Ninomiya H, Uehara H, Lim Choi Y, Satoh Y, Okumura S, Nakagawa K, Mano H, Ishikawa Y.
    Nat Med; 2012 Feb 12; 18(3):378-81. PubMed ID: 22327623
    [Abstract] [Full Text] [Related]

  • 14. ROS1-rearranged lung cancer: a clinicopathologic and molecular study of 15 surgical cases.
    Yoshida A, Kohno T, Tsuta K, Wakai S, Arai Y, Shimada Y, Asamura H, Furuta K, Shibata T, Tsuda H.
    Am J Surg Pathol; 2013 Apr 12; 37(4):554-62. PubMed ID: 23426121
    [Abstract] [Full Text] [Related]

  • 15. Ligation-dependent RT-PCR: a new specific and low-cost technique to detect ALK, ROS, and RET rearrangements in lung adenocarcinoma.
    Piton N, Ruminy P, Gravet C, Marchand V, Colasse É, Lamy A, Naoures Mear CL, Bibeau F, Marguet F, Guisier F, Salaün M, Thiberville L, Jardin F, Sabourin JC.
    Lab Invest; 2018 Mar 12; 98(3):371-379. PubMed ID: 29251734
    [Abstract] [Full Text] [Related]

  • 16. Coexistent genetic alterations involving ALK, RET, ROS1 or MET in 15 cases of lung adenocarcinoma.
    Tang Z, Zhang J, Lu X, Wang W, Chen H, Robinson MK, Cheng J, Tang G, Medeiros LJ.
    Mod Pathol; 2018 Feb 12; 31(2):307-312. PubMed ID: 28914263
    [Abstract] [Full Text] [Related]

  • 17. The frequency and impact of ROS1 rearrangement on clinical outcomes in never smokers with lung adenocarcinoma.
    Kim HR, Lim SM, Kim HJ, Hwang SK, Park JK, Shin E, Bae MK, Ou SH, Wang J, Jewell SS, Kang DR, Soo RA, Haack H, Kim JH, Shim HS, Cho BC.
    Ann Oncol; 2013 Sep 12; 24(9):2364-70. PubMed ID: 23788756
    [Abstract] [Full Text] [Related]

  • 18. Histopathologic characteristics of advanced-stage ROS1-rearranged non-small cell lung cancers.
    Park E, Choi YL, Ahn MJ, Han J.
    Pathol Res Pract; 2019 Jul 12; 215(7):152441. PubMed ID: 31085007
    [Abstract] [Full Text] [Related]

  • 19. Unique prevalence of oncogenic genetic alterations in young patients with lung adenocarcinoma.
    Tanaka K, Hida T, Oya Y, Yoshida T, Shimizu J, Mizuno T, Kuroda H, Sakakura N, Yoshimura K, Horio Y, Sakao Y, Yatabe Y.
    Cancer; 2017 May 15; 123(10):1731-1740. PubMed ID: 28177518
    [Abstract] [Full Text] [Related]

  • 20. ROS1 immunohistochemistry for detection of ROS1-rearranged lung adenocarcinomas.
    Sholl LM, Sun H, Butaney M, Zhang C, Lee C, Jänne PA, Rodig SJ.
    Am J Surg Pathol; 2013 Sep 15; 37(9):1441-9. PubMed ID: 23887156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.